does, while lasting much longer in our system: the GLP-1RAs. The very first GLP-1RA approved for type 2 diabetes was the drug exenatide
The reporting rates of GLP-1RA-associated neoplasms were compared with different comparators in five models: 1) other drugs excluding GLP-1RA (non-GLP-1RA) without indication restrictions; 2) non-GLP-1RA when diabetes as an indication because diabetes itself increases the risk of cancers; 3) patients were excluded who already had tumors before
There 9 types of antidiabetic drugs, of which GLP-1RAs are the most popular, find the evolution of GLP-1RAs and their challenges and
GLP-1RA drugs have been used in clinical practice since the mid-2024s. The first GLP-1RA was approved by the FDA (U.S. Food and Drug
In addition to already marketed GLP-1RAs, new GLP-1RA therapies by other companies will also likely crowd the market. Pfizer's GLP-1RA
From the FDA approval of the first GLP-1RA drug to the approval of oral semaglutide today, GLP-1RA has undergone several iterations. With the
A new study suggests a potential link between GLP-1RA drugs like Ozempic and the need for antidepressants. GLP-1RA users were more likely to be
GLP-1RAs is the most populat anti-diabetic drugs, now dual GLP-1RAs are emerging for treating diabets
A new study suggests a potential link between GLP-1RA drugs like Ozempic and the need for antidepressants. GLP-1RA users were more likely to
Comments